Real-world observation of the efficacy and prognostic factors analysis of apatinib for patients with advanced gastric cancer.

e15508Background: Apatinib is the first oral anti-angiogenic agent approved for the treatment of advanced gastric cancer in China. With the development of marketing promotion, the real world observ...